Natco Pharma informs about press release

03 Jun 2016 Evaluate

Natco Pharma has informed about a Press Release dated June 03, 2016 titled ‘NATCO receives USFDA tentative approval for Sorafenib Tablets, 200mg’.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

903.30 6.25 (0.70%)
31-Dec-2025 09:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1724.00
Dr. Reddys Lab 1265.00
Cipla 1496.65
Zydus Lifesciences 907.20
Lupin 2097.15
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×